[TOP GLOVE CORP BHD，通过内部成长以及通过并购和合资企业来扩大其制造能力]

顶级手套实现3QFY18销售收入11亿令吉，同比增长26.6％。除税前利润和税后利润也分别上升至1.342亿令吉和1.194亿令吉，分别比上一季度同比增长46.7％和54.1％。与此同时，销售量从3QFY17飙升37％的历史新高。

在9个月的时间里，顶级手套销售收入达到30亿令吉，比9MFY17高出19.6％。除税前利润为3.807亿马币，税后利润为3.353亿马币，这两个数字均超过2017财年全年。

随着手套的需求量增加，顶级手套的平衡产品组合的定位非常适合。亚洲地区（印度，中国和越南的需求增长9个月超过100％）以及东欧和拉丁美洲的需求增长尤其强劲。由于较高的机器利用率，更强劲的手套需求也带来更好的成本效益，从而为顶级手套的良好表现作出贡献。顶级手套专注于持续的质量和成本改进计划，并利用技术进步来应对业务挑战，这也得到了改善盈利能力。原材料价格与第三季度相比有所下降，平均天然胶乳价格处于下降趋势，降低38％至每公斤RM4.38，平均丁腈胶价格也下跌14.2％至USD1.15 / kg。

顶级手套实现销售收入11亿令吉，QoQ增长14.8％。除税前利润也录得较高的1.342亿令吉，较二季度同比增长7.8％。同时，销售额与去年同期相比增长8％。财务的提高归功于生产效率和质量的提高，加上新的产能加进去和强劲的需求增长。天然橡胶胶乳平均价格下降0.5％，而平均丁腈胶乳价格呈上涨趋势，上涨8.5％。

前景：
作为一个成长和充满活力的公司，顶级手套将继续通过内部成长以及通过并购和合资企业来扩大其制造能力。工厂31（2018年7月投入使用）和工厂32（2019年初投入运营）的建设工作正在进行中，该工程完成后将使本集团的生产线总数增加74条，年生产能力增加74亿条。同时，顶级手套的安全套生产设施预计将于2018年6月底投入使用。顶级手套于二零一八年四月五日完成收购Aspion Sdn. Bhd.并进行整合两项业务。根据顶级手套的扩张计划，于二零一八年五月，顶级手套亦完成收购Duramedical Sdn. Bhd.，一家生产和销售口腔卫生产品的公司，购买价格为285万令吉。此次收购代表了一项向医疗相关产品多元化的举措，以迎合其客户群。

截至2018年5月31日，顶级手套的财务状况依然健康，营运资金状况良好。根据其提高股东价值的承诺，顶级手套宣布派发中期股息7仙，将于2018年7月17日支付。董事会还建议每发放一股红利持有一股现有顶级手套股份，待股东于稍后召开的股东特别大会上批准。

在另一项发展中，自2018年6月1日起，顶级手套被列入MSCI全球标准指数的组成部分，以表彰其强劲而持续的增长。就前景而言，顶级手套仍然乐观。

觉得不错就SHARE 出去吧。

James Ng

The Group achieved 3QFY18 Sales Revenue of RM1.1 billion, a 26.6% increased year-on-year. Both Profit before tax and after tax also rose to RM134.2 million and RM119.4 million, which increased by 46.7% and 54.1% respectively compared with 3QFY17. Meanwhile, Sales Volume (Quantity Sold) surged by a record historical high of 37% from 3QFY17.

On a 9 months basis, the Group attained Sales Revenue of RM3 billion, 19.6% higher than 9MFY17. Profit Before Tax came in at RM380.7 million, while Profit After Tax was RM335.3 million, both figures surpassing full year for FY2017.

The excellent set of numbers followed increased glove demand, which Top Glove’s balanced product mix is well positioned to cater for. Stronger demand growth stemmed particularly from Asia (where demand growth from India, China and Vietnam exceeded 100% on a 9-month basis), as well as Eastern Europe and Latin America. The stronger glove demand also led to better cost efficiencies resulting from a higher utilisation rate, thereby contributing to the Group’s good performance. Top Glove’s focus on continuous quality and cost improvement initiatives, and harnessing technological advances to address business challenges also accounted for the improved profitability. Raw material prices were lower compared with 3QFY17, with the average natural rubber latex price on the downtrend, easing 38% to RM4.38/kg, and the average nitrile latex price also eased by 14.2% to USD1.15/kg.

The Group achieved Sales Revenue of RM1.1 billion, a 14.8% increase quarter-on-quarter. Profit Before Tax also registered higher at RM134.2 million, representing an improvement of 7.8% compared with 2QFY18. Meanwhile, sales volume grew 8% versus 2QFY18. The improved performance was attributed to improvements in production efficiency and quality, coupled with new capacity coming onstream and strong demand growth. The average natural rubber latex price eased 0.5%, while the average nitrile latex price was on the uptrend, increasing by 8.5%.

Prospects:
As a growing and dynamic company, Top Glove will continue to expand its manufacturing capabilities, organically as well as through M&As and joint ventures. The construction of Factory 31 (operational by July 2018) and Factory 32 (operational by early 2019) is underway, which upon completion, will increase the Group’s total number of production lines by an additional 74 lines and production capacity by 7.4 billion gloves per annum. Meanwhile, Top Glove's condom manufacturing facility is expected to be operational by end of June 2018.
The Group completed its acquisition of Aspion Sdn. Bhd. on 5 April 2018 and integration of the 2 businesses is in progress. In line with the Group’s expansion plans, in May 2018, Top Glove also completed its acquisition of Duramedical Sdn. Bhd., a company manufacturing and marketing dental hygiene products such as dental dams, for the purchase consideration of RM2.85 million. The exercise represents an initiative to diversify into medical related products catering to its customer base.

The Group’s financial position remained healthy as at 31 May 2018, with healthy working capital position. Consistent with its commitment to enhance the value delivered to shareholders, the Group declared an interim dividend of 7 sen, to be paid on 17 July 2018. The Board of Directors also proposed to undertake a bonus issue on the basis of one bonus share for every one existing Top Glove share held, subject to shareholder approval during an extraordinary general meeting to be convened later.

In another development, Top Glove was included as a constituent of the MSCI Global Standard Index effective 1 June 2018, in recognition of its strong and consistent growth. The Group remains upbeat in terms of outlook.

If you think this post is beneficial, please share it.

James Ng